跳至主要内容
临床试验/JPRN-jRCTs031200195
JPRN-jRCTs031200195已完成未知

Evaluation of intraoperative localization by indocyanine green (ICG) injection for laparoscopic colorectal cancer surgery -Single-center prospective study

SHIGEKI YAMAGUCHI0 个研究点目标入组 38 人开始时间: 2020年11月11日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
38

研究概览

简要总结

ICG injection is a useful tool for determining tumor localization. Since no adverse events were observed, it is considered a safe method for intraoperative tumor localization diagnosis.

研究设计

研究类型
Interventional

入排标准

年龄范围
> 20age old 至 ot applicable(—)
性别
All

入选标准

  • 1. Patients who are hospitalized or hospitalized for department of surgery, institute of gastroenterology, Tokyo Women's Medical University.
  • 2. Men and women over the age of 20 at the time of obtaining consent.
  • 3. Patients diagnosed with colon cancer and rectal cancer.
  • 4. Patients scheduled for laparoscopic or robot-assisted surgery for colon cancer and rectal cancer
  • 5. Patients who can undergo lower gastrointestinal endoscopy and local injection 2-3 days before surgery
  • 6. Patients who have a thorough understanding after receiving a sufficient explanation for participation in this study and have the free written consent of the patient.
  • 7. For all inspection items, use the latest inspection values within 56 days before registration. Inspection on the same day 8 weeks before the registration date is allowed. )
  • A) White blood cell count 3,000 /mm3 or less
  • B) Platelet count100,000 /mm3 or less
  • C) AST 100 IU/L or more, ALT 100 IU/L or more
  • D) Total bilirubin2.0 g/dl ore more
  • E) Serum creatinine1.5 mg/dl or more

排除标准

  • 1. Patients with iodine and ICG allergies.
  • 2. Cases of emergency surgery, cases of severe stenosis, cases of colonic stent placement, and cases judged to be in poor general condition by the principal investigator are excluded.
  • 3. Patients who are judged to be inappropriate by the principal investigator.

研究者

发起方
SHIGEKI YAMAGUCHI

相似试验